RMHI Retrieve Medical Holdings, Inc.

OTC Pharmaceutical Preparations NV CIK: 0001452804
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

RMHI exhibits critical insolvency with negative stockholders equity of -$603.4K and zero revenue generation. The company is depleting its minimal cash reserves with negative operating cash flows while incurring persistent operating losses, indicating operational collapse. Severely outdated financial data (Dec 2022) prevents current assessment and combined with balance sheet insolvency suggests extreme distress.

Strengths

  • + Minimal cash reserves of $96.7K provide limited operational runway
  • + No long-term debt obligations reported
  • + Low total asset base limits downside exposure to creditors

Risks

  • ! Negative stockholders equity of -$603.4K indicates technical insolvency and bankruptcy risk
  • ! Zero revenue with negative operating cash flow of -$30.9K demonstrates no viable business operations
  • ! Financial data from December 2022 is extremely outdated, preventing accurate current assessment and potential delisting risk

Key Metrics to Watch

Financial Metrics

Revenue
0.0
Net Income
-112.2K
EPS (Diluted)
$0.00
Free Cash Flow
-30.9K
Total Assets
102.5K
Cash
96.7K

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -109.5%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
0.00x
Quick Ratio
-0.32x
Debt/Equity
N/A
Debt/Assets
688.8%
Interest Coverage
-60.33x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-09T22:10:21.865933 | Data as of: 2022-12-31 | Powered by Claude AI